Nicorandil for moderate to severe rheumatoid arthritis
Treatments studied
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study tests whether a heart medication called nicorandil can help reduce arthritis symptoms when added to your current treatment. It is for people with moderate to severe rheumatoid arthritis who have been stable on their current treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have a confirmed diagnosis of moderate to severe rheumatoid arthritis.
- You must have been on the same basic treatment for at least 3 months without changes.
- You must not have other autoimmune diseases, active cancer, or serious heart or stomach conditions.
- You must not be pregnant or breastfeeding, and cannot take certain medicines like sildenafil (Viagra) or some antidepressants.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medicine called nicorandil, which is normally used for chest pain, to see if it can lower the risk of heart disease in people with rheumatoid arthritis. If you have RA and are already on standard treatment, this may help protect your heart.
This trial tests whether adding L-carnitine (a natural substance) to your current treatment helps reduce rheumatoid arthritis symptoms. It could be an option if your arthritis is still active despite taking standard medications.
This trial compares two additional medicines (diosmin or rebamipide) taken with standard arthritis treatment to see if they help reduce joint pain and swelling better than standard treatment alone.
This study tests whether niacin, a common vitamin, can help reduce inflammation and improve disease activity in people with rheumatoid arthritis who also have high cholesterol. It may offer an additional treatment option without the need for biologics.
This study tests whether nicorandil, a heart medication with anti-inflammatory properties, can help reduce joint inflammation and swelling in people with active rheumatoid arthritis who are already taking conventional disease-modifying drugs. The goal is to see if it provides additional relief from symptoms.
This trial tests if taking a vitamin B3 supplement (nicotinamide) can improve outcomes for people with rheumatoid arthritis. Researchers want to see if adding this over-the-counter vitamin to your usual arthritis medicines helps reduce disease activity.
Hear when a new Rheumatoid Arthritis (RA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.